Flutiform 50 microgram / 5 microgram / dosis aërosol, suspensie Ολλανδία - Ολλανδικά - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

flutiform 50 microgram / 5 microgram / dosis aërosol, suspensie

mundipharma pharmaceuticals b.v. leusderend 24 3832 rc leusden - fluticasonpropionaat 50 µg/dosis ; formoterolfumaraat 2-water 5 µg/dosis samenstelling overeenkomend met ; formoterol 4,1 µg/dosis - aërosol, suspensie - dinatriumcromoglicaat ; ethanol ; heptafluoropropaan, - formoterol and fluticasone

Travoprost/Timolol ratiopharm 40 microgram/ml + 5 mg/ml oogdruppels, oplossing Ολλανδία - Ολλανδικά - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

travoprost/timolol ratiopharm 40 microgram/ml + 5 mg/ml oogdruppels, oplossing

ratiopharm gmbh - timololmaleaat samenstelling overeenkomend met ; timolol 0-water ; travoprost - oogdruppels, oplossing - benzalkoniumchloride ; boorzuur (e 284) ; dinatriumedetaat 2-water ; macrogolglycerolhydroxystearaat ; mannitol (d-) (e 421) ; natriumhydroxide (e 524) ; trometamol ; water voor injectie, - timolol, combinations

BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15% solution/ drops Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

brimonidine tartrate ophthalmic solution, 0.15% solution/ drops

alembic pharmaceuticals inc. - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brimonidine tartrate ophthalmic solution, 0.15% is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension. brimonidine tartrate ophthalmic solution is contraindicated in neonates and infants (under the age of 2 years). brimonidine tartrate ophthalmic solution is contraindicated in patients who have exhibited a hypersensitivity reaction to any component of this medication in the past. pregnancy category b: teratogenicity studies have been performed in animals. brimonidine tartrate was not teratogenic when given orally during gestation days 6 through 15 in rats and days 6 through 18 in rabbits. the highest doses of brimonidine tartrate in rats (2.5 mg/kg/day) and rabbits (5.0 mg/kg/day) achieved auc exposure values 360- and 20-fold higher, or 260- and 15-fold higher, respectively, than similar values estimated in humans treated with brimonidine tartrate ophthalmic solution 0.15%,1 drop in both eyes three

BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15% solution/ drops Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

brimonidine tartrate ophthalmic solution, 0.15% solution/ drops

alembic pharmaceuticals limited - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brimonidine tartrate ophthalmic solution, 0.15% is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension. brimonidine tartrate ophthalmic solution is contraindicated in neonates and infants (under the age of 2 years). brimonidine tartrate ophthalmic solution is contraindicated in patients who have exhibited a hypersensitivity reaction to any component of this medication in the past. pregnancy category b: teratogenicity studies have been performed in animals. brimonidine tartrate was not teratogenic when given orally during gestation days 6 through 15 in rats and days 6 through 18 in rabbits. the highest doses of brimonidine tartrate in rats (2.5 mg/kg/day) and rabbits (5.0 mg/kg/day) achieved auc exposure values 360- and 20-fold higher, or 260- and 15-fold higher, respectively, than similar values estimated in humans treated with brimonidine tartrate ophthalmic solution 0.15%,1 drop in both eyes three

CoAmox-Acino 156.25 Pulver zur Herstellung einer Suspension zum Einnehmen Ελβετία - Γερμανικά - Swissmedic (Swiss Agency for Therapeutic Products)

coamox-acino 156.25 pulver zur herstellung einer suspension zum einnehmen

acino pharma ag - amoxicillinum anhydricum, säure clavulanicum - pulver zur herstellung einer suspension zum einnehmen - amoxicillinum anhydricum 125 mg ut amoxicillinum trihydricum, acidum clavulanicum 31.25 mg ut kalii clavulanas, silica colloidalis anhydrica, xanthani gummi, crospovidonum, carmellosum natricum, aromatica (erdbeer) cum alcohol benzylicus et propylenglycolum, aspartamum 8.32 mg, ad suspensionem corresp. suspensio reconstituta 5 ml corresp. natrium max. 2.35 mg. - infektionskrankheiten - synthetika

DEFINITY Suspension Καναδάς - Γαλλικά - Health Canada

definity suspension

lantheus mi canada inc - perflutrène - suspension - 150mcl - perflutrène 150mcl - other diagnostic agents

Saracen Delta Suspensionskoncentrat Δανία - Δανικά - SEGES Landbrug & Fødevarer

saracen delta suspensionskoncentrat

fmc agricultural solutions a/s (tidligere: cheminova a/s) - florasulam, diflufenican - suspensionskoncentrat - 50 g/l florasulam ; 500 g/l diflufenican

Saracen Suspensionskoncentrat Δανία - Δανικά - SEGES Landbrug & Fødevarer

saracen suspensionskoncentrat

fmc agricultural solutions a/s (tidligere: cheminova a/s) - florasulam - suspensionskoncentrat - 50 g/l florasulam

DEFINITY SUSPENSION Καναδάς - Αγγλικά - Health Canada

definity suspension

lantheus mi canada inc - perflutren - suspension - 150mcl - perflutren 150mcl - other diagnostic agents

Flight Xtra Suspensionskoncentrat Δανία - Δανικά - SEGES Landbrug & Fødevarer

flight xtra suspensionskoncentrat

basf a/s - picolinafen, pendimethalin - suspensionskoncentrat - 16 g/l picolinafen ; 320 g/l pendimethalin